Astec Lifesciences has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on October 27, 2016, to consider and approve the Standalone and Consolidated Unaudited Financial results for the Quarter and Half Year ended September 30, 2016 (subject to limited review by the Statutory Auditors of the Company), after these results are reviewed by the Audit Committee.
The above information is a part of company’s filings submitted to BSE.